American Journal of Transplantation
NIH to Lift Moratorium on Chimera Research Funding
Ionic Checkpoint
Measuring What Matters
Recipients Inherit a Cardiovascular Risk Factor From Bone Marrow Donors
Signatures of Tolerance or Immunosuppression?
DAMP—Induced Allograft and Tumor Rejection
Transplantation and Damage‐Associated Molecular Patterns (DAMPs)
Micro and Nano Material Carriers for Immunomodulation
Potential Implications of Recent and Proposed Changes in the Regulatory Oversight of Solid Organ Transplantation in the United States
The Ethics of Promoting Living Kidney Donation Using Nonargumentative Influence
The Long‐Term Follow‐up and Support for Living Organ Donors
Bone Marrow Cell Transplant From Donors With Cardiovascular Risk Factors Increases the Pro‐atherosclerotic Phenotype in the Recipients
The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses
Anti‐LG3 Antibodies Aggravate Renal Ischemia–Reperfusion Injury and Long‐Term Renal Allograft Dysfunction
Transcriptomic Signature of the CD24hiCD38hi Transitional B Cells Associated With an Immunoregulatory Phenotype in Renal Transplant Recipients
Biomarkers of Tolerance in Kidney Transplantation
Clinical Significance of Pretransplant Donor‐Specific Antibodies in the Setting of Negative Cell‐Based Flow Cytometry Crossmatching in Kidney Transplant Recipients
Plasma‐Derived C1 Esterase Inhibitor for Acute Antibody‐Mediated Rejection Following Kidney Transplantation
Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States
Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients
Health Insurance Trends in United States Living Kidney Donors (2004 to 2015)
First‐Degree Living‐Related Donor Liver Transplantation in Autoimmune Liver Diseases
Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart–Liver Transplantation
Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End‐Stage Renal Disease
Patterns of End‐Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors
A Smartphone App for Increasing Live Organ Donation
Living Organ Donation by Minors
Coccidioidomycosis Transmission Through Organ Transplantation
APOL1‐Associated End‐Stage Renal Disease in a Living Kidney Transplant Donor
Contaminated Devices Putting Open‐Heart Surgery Patients at Risk
Late Choledochojejunostomy Dysfunction After Liver Transplantation for Primary Sclerosing Cholangitis
Allocation Based on Virtual Crossmatch Alone
Reply to “Allocation Based on Virtual Crossmatch Alone
A Potential Solution to Make the Best Use of a Living Donor–Deceased Donor List Exchange
We Need to Take the Next Step